Product Launch (Blog)

Jul, 10 2023

Unveiling the Power of Microbial Identification: Exploring Insights into the Global Market

Microbial identification techniques play a crucial role in understanding microorganisms' characteristics and environmental interactions. These techniques are essential in various industries as microbes can cause contamination and impact product quality and safety. The adoption of microbial identification methods has surpassed traditional culture-based approaches due to their advantages, such as faster results and reduced risk of errors. These advanced techniques enable accurate identification, tracking, and control of microbial populations, improving product quality and safety across diverse sectors.

According to Data Bridge Market Research the Microbial Identification Market accounted for USD 4.06 billion in 2022, and expected to reach USD 10.58 billion by 2030. The market is expected to grow with a CAGR of 12.7% in the forecast period of 2023 to 2030.

“Increasing cases of infectious diseases”

The escalating occurrence of infectious diseases necessitates the detection of their causative microorganisms. Recent data from the World Health Organization (WHO) highlighted two fatal Marburg virus disease (MVD) cases in Ghana's Ashanti region, subsequently testing positive for the Marburg virus. Furthermore, the global tuberculosis report for 2022 estimated a staggering 10.6 million individuals affected by TB worldwide in 2021. This surge in prevalence underscores the critical need for rapid and accurate microbial identification, driving market growth in this sector.

What restraints the growth of the microbial identification market?

“High cost of microbial process”

The increasing costs of microbiological examinations can be attributed to various factors. These include the need for sophisticated laboratory equipment and supplies, specialized training for laboratory personnel, and the continuous development of new testing methodologies. The stringent quality control measures and regulatory requirements add to the overall expenses. The rising costs pose challenges for healthcare facilities, laboratories, and patients, impacting the accessibility and affordability of microbiological examinations and potentially limiting their widespread adoption and utilization.

Segmentation: Global Microbial Identification Market

The microbial identification market is segmented on the basis of product and service, type, method, technology, application, and end users.

  • On the basis of product and service, the microbial identification market is segmented into instruments, consumables, services.
  • On the basis of type, the microbial identification market is segmented into fully automatic type, semi-automatic type.
  • On the basis of method, the microbial identification market is segmented into phenotypic methods, genotypic methods, proteomic based methods.
  • On the basis of technology, the microbial identification market is segmented into mass spectrometry, PCR.
  • On the basis of application, the microbial identification market is segmented into diagnostic applications, food testing, pharmaceutical applications, cosmetics and personal care products testing, environmental applications, others.
  • On the basis of end users, the microbial identification market is segmented into hospitals, diagnostic laboratories, and blood banks, beverage manufacturing companies, pharmaceutical companies, others.

Regional Insights: North America dominates the Microbial Identification Market

North America dominates the microbial identification market is propelled by its advanced healthcare infrastructure and consistent investments in the healthcare sector. Additionally, the increasing focus on food safety further contributes to the market growth in this region.

Asia-Pacific is expected to grow significantly, driven by the increasing attention of significant players towards emerging Asian countries. Furthermore, the market is supported by vital government initiatives, which play an essential role in driving growth in this region.

To know more about the study visit,

Recent Developments

  • In 2022, Bruker Corporation advanced its new multiplex PCR infectious disease assays based on its LiquidArray technology. The company also extended its mycobacteria portfolio with the FluoroType Mycobacteria PCR assay. It launched the high-precision FluoroCycler XT thermocycler. It utilizes powerful LiquidArray technology to distinguish between 31 clinically relevant non-tuberculous mycobacteria and the M. tuberculosis complex from cultures in a single test.

The Prominent Key Players Operating in the Microbial Identification Market Include:

  • Shimadzu Corporation (Japan)
  • BIOLOG (U.K.)
  • Wickham Micro Limited (U.K.)
  • Merck KGaA (Germany)
  • Danaher (U.S.)
  • MicroPort Scientific Corporation (China).
  • QXMédical (U.S.), Meril Life Sciences Pvt. Ltd (India)
  •  Abbott (U.S.)
  • bioMérieux (France)
  • Bio-Rad Laboratories, Inc (U.S.)
  • Thermo Fisher Scientific Inc (U.S.)
  • BD (U.S.)
  • Eurofins Scientific (France)

Above are the key players covered in the report, to know about more and exhaustive list of microbial identification market companies contact,

Research Methodology: Global Microbial Identification Market

Data collection and base year analysis are done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. In addition, market share analysis and key trend analysis are the major success factors in the market report. The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Global vs Regional and Vendor Share Analysis. Please request analyst call in case of further inquiry.

Client Testimonials